• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta 分泌酶切割的 Tau 拮抗 TrkB 神经营养信号,介导阿尔茨海默病病理学。

Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.

机构信息

Department of Neurobiology, Fourth Military Medical University, Xi'an, 710032 Shaanxi, People's Republic of China.

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322.

出版信息

Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9094-9102. doi: 10.1073/pnas.1901348116. Epub 2019 Apr 19.

DOI:10.1073/pnas.1901348116
PMID:31004063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6500177/
Abstract

BDNF, an essential trophic factor implicated in synaptic plasticity and neuronal survival, is reduced in Alzheimer's disease (AD). BDNF deficiency's association with Tau pathology in AD is well documented. However, the molecular mechanisms accounting for these events remain incompletely understood. Here we show that BDNF deprivation triggers Tau proteolytic cleavage by activating δ-secretase [i.e., asparagine endopeptidase (AEP)], and the resultant Tau N368 fragment binds TrkB receptors and blocks its neurotrophic signals, inducing neuronal cell death. Knockout of BDNF or TrkB receptors provokes δ-secretase activation via reducing T322 phosphorylation by Akt and subsequent Tau N368 cleavage, inducing AD-like pathology and cognitive dysfunction, which can be restored by expression of uncleavable Tau N255A/N368A mutant. Blocking the Tau N368-TrkB complex using Tau repeat-domain 1 peptide reverses this pathology. Thus, our findings support that BDNF reduction mediates Tau pathology via activating δ-secretase in AD.

摘要

脑源性神经营养因子(BDNF)是一种重要的营养因子,参与突触可塑性和神经元存活,在阿尔茨海默病(AD)中减少。BDNF 缺乏与 AD 中的 Tau 病理学的关联已有充分的文献记载。然而,这些事件的分子机制仍不完全清楚。在这里,我们表明 BDNF 的剥夺通过激活 δ-分泌酶(即天冬酰胺内肽酶(AEP))触发 Tau 蛋白的蛋白水解切割,并且所得的 Tau N368 片段结合 TrkB 受体并阻断其神经营养信号,诱导神经元细胞死亡。BDNF 或 TrkB 受体的敲除通过降低 Akt 介导的 T322 磷酸化和随后的 Tau N368 切割来引发 δ-分泌酶的激活,诱导类似 AD 的病理学和认知功能障碍,可通过表达不可切割的 Tau N255A/N368A 突变体来恢复。使用 Tau 重复结构域 1 肽阻断 Tau N368-TrkB 复合物可逆转这种病理。因此,我们的研究结果支持 BDNF 减少通过在 AD 中激活 δ-分泌酶介导 Tau 病理学。

相似文献

1
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.Delta 分泌酶切割的 Tau 拮抗 TrkB 神经营养信号,介导阿尔茨海默病病理学。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9094-9102. doi: 10.1073/pnas.1901348116. Epub 2019 Apr 19.
2
Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.BDNF/TrkB 神经营养活性缺乏通过上调阿尔茨海默病中的 C/EBPβ 刺激 δ-分泌酶。
Cell Rep. 2019 Jul 16;28(3):655-669.e5. doi: 10.1016/j.celrep.2019.06.054.
3
Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.创伤性脑损伤通过 δ-分泌酶触发 APP 和 Tau 的裂解,介导阿尔茨海默病病理。
Prog Neurobiol. 2020 Feb;185:101730. doi: 10.1016/j.pneurobio.2019.101730. Epub 2019 Nov 25.
4
Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.针对脑源性神经营养因子/TrkB 通路和 δ 分泌酶治疗阿尔茨海默病。
Neuropharmacology. 2021 Oct 1;197:108737. doi: 10.1016/j.neuropharm.2021.108737. Epub 2021 Jul 31.
5
BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.BDNF 通过 AKT 磷酸化抑制神经退行性疾病相关天冬酰胺内肽酶活性。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.99007.
6
Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.神经营养信号缺陷加剧了阿尔茨海默病发病的环境风险。
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25). doi: 10.1073/pnas.2100986118.
7
Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.C/EBPβ/δ-分泌酶轴的时空激活调节阿尔茨海默病的发病机制。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12427-E12434. doi: 10.1073/pnas.1815915115. Epub 2018 Dec 10.
8
TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.Delta- 分泌酶切割 TrkB 受体使其不能磷酸化 APP,加重阿尔茨海默病病理。
Mol Psychiatry. 2021 Jul;26(7):2943-2963. doi: 10.1038/s41380-020-00863-8. Epub 2020 Aug 11.
9
7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.7,8-二羟基黄酮,一种小分子 TrkB 激动剂,可逆转阿尔茨海默病小鼠模型中的记忆缺陷和 BACE1 升高。
Neuropsychopharmacology. 2012 Jan;37(2):434-44. doi: 10.1038/npp.2011.191. Epub 2011 Sep 7.
10
Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.阻断 GSK3β 介导的动力蛋白 1 磷酸化增强了 BDNF 依赖性的 TrkB 内吞作用,并且增强了 BDNF 在阿尔茨海默病的神经元和小鼠模型中的保护作用。
Neurobiol Dis. 2015 Feb;74:377-91. doi: 10.1016/j.nbd.2014.11.020. Epub 2014 Dec 5.

引用本文的文献

1
BIN1 Interacts with Tau Fragments to Inhibit TrkB Signaling Endosome Recycling in a Mouse Model of Alzheimer's Disease.在阿尔茨海默病小鼠模型中,BIN1与Tau片段相互作用以抑制TrkB信号内体循环。
Neurosci Bull. 2025 Jun 18. doi: 10.1007/s12264-025-01435-y.
2
Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition.针对tau片段的免疫疗法可减轻阿尔茨海默病病理,改善突触功能和认知。
Mol Neurodegener. 2025 May 27;20(1):60. doi: 10.1186/s13024-025-00854-9.
3
Harnessing BDNF Signaling to Promote Resilience in Aging.利用脑源性神经营养因子信号通路促进衰老过程中的恢复力。
Aging Dis. 2024 Nov 27. doi: 10.14336/AD.2024.0961.
4
A Combined Computational and Experimental Approach to Studying Tropomyosin Kinase Receptor B Binders for Potential Treatment of Neurodegenerative Diseases.一种联合计算与实验的方法,用于研究原肌球蛋白激酶受体 B 配体,以潜在治疗神经退行性疾病。
Molecules. 2024 Aug 23;29(17):3992. doi: 10.3390/molecules29173992.
5
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.阿尔茨海默病的最新进展:机制、临床试验和新药研发策略。
Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3.
6
The effects of exercise interventions on brain-derived neurotrophic factor levels in children and adolescents: a meta-analysis.运动干预对儿童和青少年脑源性神经营养因子水平的影响:一项荟萃分析。
Neural Regen Res. 2025 May 1;20(5):1513-1520. doi: 10.4103/NRR.NRR-D-23-01296. Epub 2024 Mar 1.
7
Psilocybin for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的裸盖菇素
Front Neurosci. 2024 Jul 10;18:1420601. doi: 10.3389/fnins.2024.1420601. eCollection 2024.
8
BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer's disease.脑源性神经营养因子 Val66Met 修饰早期散发性阿尔茨海默病的情景记忆下降和 tau 生物标志物增加。
Arch Clin Neuropsychol. 2024 Aug 24;39(6):683-691. doi: 10.1093/arclin/acae014.
9
A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer's disease mouse models through attenuating mitochondrial function.在阿尔茨海默病小鼠模型中,一种tau片段通过削弱线粒体功能将类似抑郁的行为与认知衰退联系起来。
Front Aging Neurosci. 2023 Dec 6;15:1293164. doi: 10.3389/fnagi.2023.1293164. eCollection 2023.
10
Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice.天冬酰胺内肽酶(AEP)抑制剂能有效治疗散发性阿尔茨海默病小鼠模型。
Neuropsychopharmacology. 2024 Feb;49(3):620-630. doi: 10.1038/s41386-023-01774-2. Epub 2023 Nov 29.

本文引用的文献

1
BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.BDNF 通过 AKT 磷酸化抑制神经退行性疾病相关天冬酰胺内肽酶活性。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.99007.
2
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.C/EBPβ 调节 δ-分泌酶的表达并介导阿尔茨海默病小鼠模型的发病机制。
Nat Commun. 2018 May 3;9(1):1784. doi: 10.1038/s41467-018-04120-z.
3
Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.SRPK2介导的δ-分泌酶磷酸化增强其酶活性,引发阿尔茨海默病的发病机制。
Mol Cell. 2017 Sep 7;67(5):812-825.e5. doi: 10.1016/j.molcel.2017.07.018. Epub 2017 Aug 17.
4
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.天冬酰胺内肽酶切割α-突触核蛋白并介导帕金森病的病理活动。
Nat Struct Mol Biol. 2017 Aug;24(8):632-642. doi: 10.1038/nsmb.3433. Epub 2017 Jul 3.
5
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.抑制 δ-分泌酶可改善阿尔茨海默病小鼠模型的认知功能。
Nat Commun. 2017 Mar 27;8:14740. doi: 10.1038/ncomms14740.
6
Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.在皮质神经元原代培养物中,由于tau蛋白过度磷酸化,脑源性神经营因子(BDNF)的分泌水平和细胞内水平均降低。
J Chem Neuroanat. 2017 Mar;80:19-26. doi: 10.1016/j.jchemneu.2016.11.007. Epub 2016 Nov 30.
7
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.在阿尔茨海默病的动物和细胞模型中,tau蛋白下调脑源性神经营养因子(BDNF)的表达。
Neurobiol Aging. 2016 Dec;48:135-142. doi: 10.1016/j.neurobiolaging.2016.08.020. Epub 2016 Aug 31.
8
Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.早期tau蛋白病小鼠模型中tau蛋白驱动的神经元和神经营养功能障碍
J Neurosci. 2016 Feb 17;36(7):2086-100. doi: 10.1523/JNEUROSCI.0774-15.2016.
9
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.δ-分泌酶切割淀粉样前体蛋白并调节阿尔茨海默病的发病机制。
Nat Commun. 2015 Nov 9;6:8762. doi: 10.1038/ncomms9762.
10
CREB expression mediates amyloid β-induced basal BDNF downregulation.CREB表达介导淀粉样蛋白β诱导的脑源性神经营养因子基础下调。
Neurobiol Aging. 2015 Aug;36(8):2406-13. doi: 10.1016/j.neurobiolaging.2015.04.014. Epub 2015 Apr 30.